Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes.
Szelag
B
B
Wroblewski
M
M
Castenfors
J
J
Henricsson
M
M
Berntorp
K
K
Fernlund
P
P
Sundkvist
G
G
D000328:Adult; D000419:Albuminuria / Q000209:etiology / Q000503:physiopathology*; D001342:Autonomic Nervous System Diseases / Q000453:epidemiology* / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology*; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology / Q000503:physiopathology*; D008875:Middle Aged; D009765:Obesity / Q000503:physiopathology*; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D015995:Prevalence; D013548:Sweden / Q000453:epidemiology
D017395:Plasminogen Activator Inhibitor 1